Truist Financial Corp lowered its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 6.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 50,769 shares of the company’s stock after selling 3,684 shares during the quarter. Truist Financial Corp owned about 0.06% of IDEXX Laboratories worth $25,389,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the stock. Scissortail Wealth Management LLC bought a new stake in IDEXX Laboratories during the first quarter worth approximately $202,883,000. L. Roy Papp & Associates LLP bought a new stake in IDEXX Laboratories during the first quarter worth approximately $285,000. ICICI Prudential Asset Management Co Ltd boosted its position in IDEXX Laboratories by 27.7% during the first quarter. ICICI Prudential Asset Management Co Ltd now owns 530 shares of the company’s stock worth $265,000 after purchasing an additional 115 shares during the period. Commerce Bank boosted its position in IDEXX Laboratories by 0.8% during the first quarter. Commerce Bank now owns 5,857 shares of the company’s stock worth $2,929,000 after purchasing an additional 46 shares during the period. Finally, Ellevest Inc. boosted its position in IDEXX Laboratories by 12.4% during the first quarter. Ellevest Inc. now owns 861 shares of the company’s stock worth $431,000 after purchasing an additional 95 shares during the period. Institutional investors own 86.53% of the company’s stock.
IDEXX Laboratories Stock Performance
Shares of NASDAQ IDXX opened at $508.34 on Tuesday. The company has a current ratio of 1.33, a quick ratio of 0.89 and a debt-to-equity ratio of 0.64. The business has a fifty day simple moving average of $501.71 and a 200 day simple moving average of $489.70. IDEXX Laboratories, Inc. has a one year low of $317.06 and a one year high of $564.73. The firm has a market capitalization of $42.20 billion, a price-to-earnings ratio of 53.96, a PEG ratio of 2.98 and a beta of 1.19.
Analyst Ratings Changes
Get Our Latest Analysis on IDXX
Insiders Place Their Bets
In other IDEXX Laboratories news, EVP Michael Lane sold 16,027 shares of the stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $510.00, for a total transaction of $8,173,770.00. Following the completion of the transaction, the executive vice president now directly owns 4,034 shares in the company, valued at $2,057,340. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Jonathan W. Ayers sold 10,000 shares of the stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $489.23, for a total transaction of $4,892,300.00. Following the sale, the director now owns 137,039 shares in the company, valued at $67,043,589.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Lane sold 16,027 shares of the stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $510.00, for a total value of $8,173,770.00. Following the sale, the executive vice president now owns 4,034 shares in the company, valued at approximately $2,057,340. The disclosure for this sale can be found here. Corporate insiders own 2.11% of the company’s stock.
IDEXX Laboratories Profile
IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Featured Stories
- Five stocks we like better than IDEXX Laboratories
- How to Invest in Grocery Stores
- 8 Best Meme Stocks to Buy Now
- What is a Mid Cap Stock? How to Invest
- Is Now The Time To Buy XLF Financial ETF?
- Financial Services Stocks Investing
- Three Ways To Play The Rise In Oil Prices
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
